tetano
Editor, Senior Moderator
Pulmonology
. 2022 Sep 15;S2531-0437(22)00211-2.
doi: 10.1016/j.pulmoe.2022.09.003. Online ahead of print.
Hyperoxemia in invasively ventilated COVID-19 patients-Insights from the PRoVENT-COVID study
A M Tsonas[SUP] 1 [/SUP], D M van Meenen[SUP] 2 [/SUP], M Botta[SUP] 2 [/SUP], G S Shrestha[SUP] 3 [/SUP], O Roca[SUP] 4 [/SUP], F Paulus[SUP] 5 [/SUP], A S Neto[SUP] 6 [/SUP], M J Schultz[SUP] 7 [/SUP], PRoVENT–COVID Collaborative Group
Affiliations
Abstract
Objective: We determined the prevalences of hyperoxemia and excessive oxygen use, and the epidemiology, ventilation characteristics and outcomes associated with hyperoxemia in invasively ventilated patients with coronavirus disease 2019 (COVID-19).
Methods: Post hoc analysis of a national, multicentre, observational study in 22 ICUs. Patients were classified in the first two days of invasive ventilation as 'hyperoxemic' or 'normoxemic'. The co-primary endpoints were prevalence of hyperoxemia (PaO[SUB]2[/SUB] > 90 mmHg) and prevalence of excessive oxygen use (FiO[SUB]2[/SUB] ≥ 60% while PaO[SUB]2[/SUB] > 90 mmHg or SpO[SUB]2[/SUB] > 92%). Secondary endpoints included ventilator settings and ventilation parameters, duration of ventilation, length of stay (LOS) in ICU and hospital, and mortality in ICU, hospital, and at day 28 and 90. We used propensity matching to control for observed confounding factors that may influence endpoints.
Results: Of 851 COVID-19 patients, 225 (26.4%) were classified as hyperoxemic. Excessive oxygen use occurred in 385 (45.2%) patients. Acute respiratory distress syndrome (ARDS) severity was lowest in hyperoxemic patients. Hyperoxemic patients were ventilated with higher positive end-expiratory pressure (PEEP), while rescue therapies for hypoxemia were applied more often in normoxemic patients. Neither in the unmatched nor in the matched analysis were there differences between hyperoxemic and normoxemic patients with regard to any of the clinical outcomes.
Conclusion: In this cohort of invasively ventilated COVID-19 patients, hyperoxemia occurred often and so did excessive oxygen use. The main differences between hyperoxemic and normoxemic patients were ARDS severity and use of PEEP. Clinical outcomes were not different between hyperoxemic and normoxemic patients.
Keywords: ARDS; COVID–19; Coronavirus disease 2019; Hyperoxemia; Invasive ventilation; Mortality; Normoxemia; Oxygen management; Ventilation.
. 2022 Sep 15;S2531-0437(22)00211-2.
doi: 10.1016/j.pulmoe.2022.09.003. Online ahead of print.
Hyperoxemia in invasively ventilated COVID-19 patients-Insights from the PRoVENT-COVID study
A M Tsonas[SUP] 1 [/SUP], D M van Meenen[SUP] 2 [/SUP], M Botta[SUP] 2 [/SUP], G S Shrestha[SUP] 3 [/SUP], O Roca[SUP] 4 [/SUP], F Paulus[SUP] 5 [/SUP], A S Neto[SUP] 6 [/SUP], M J Schultz[SUP] 7 [/SUP], PRoVENT–COVID Collaborative Group
Affiliations
- PMID: 36274046
- DOI: 10.1016/j.pulmoe.2022.09.003
Abstract
Objective: We determined the prevalences of hyperoxemia and excessive oxygen use, and the epidemiology, ventilation characteristics and outcomes associated with hyperoxemia in invasively ventilated patients with coronavirus disease 2019 (COVID-19).
Methods: Post hoc analysis of a national, multicentre, observational study in 22 ICUs. Patients were classified in the first two days of invasive ventilation as 'hyperoxemic' or 'normoxemic'. The co-primary endpoints were prevalence of hyperoxemia (PaO[SUB]2[/SUB] > 90 mmHg) and prevalence of excessive oxygen use (FiO[SUB]2[/SUB] ≥ 60% while PaO[SUB]2[/SUB] > 90 mmHg or SpO[SUB]2[/SUB] > 92%). Secondary endpoints included ventilator settings and ventilation parameters, duration of ventilation, length of stay (LOS) in ICU and hospital, and mortality in ICU, hospital, and at day 28 and 90. We used propensity matching to control for observed confounding factors that may influence endpoints.
Results: Of 851 COVID-19 patients, 225 (26.4%) were classified as hyperoxemic. Excessive oxygen use occurred in 385 (45.2%) patients. Acute respiratory distress syndrome (ARDS) severity was lowest in hyperoxemic patients. Hyperoxemic patients were ventilated with higher positive end-expiratory pressure (PEEP), while rescue therapies for hypoxemia were applied more often in normoxemic patients. Neither in the unmatched nor in the matched analysis were there differences between hyperoxemic and normoxemic patients with regard to any of the clinical outcomes.
Conclusion: In this cohort of invasively ventilated COVID-19 patients, hyperoxemia occurred often and so did excessive oxygen use. The main differences between hyperoxemic and normoxemic patients were ARDS severity and use of PEEP. Clinical outcomes were not different between hyperoxemic and normoxemic patients.
Keywords: ARDS; COVID–19; Coronavirus disease 2019; Hyperoxemia; Invasive ventilation; Mortality; Normoxemia; Oxygen management; Ventilation.